A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)
Clinical trial NCT02336230 · COMPLETED
Trial details
- NCT number
- NCT02336230
- Sponsor
- Mesoblast, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2018-04-09
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.